ZURA a med tech microcap with catalysts LONGZURA a penny stock has catalysts- an FDA action is soon upcoming and an insider bought a lot
more shares. The 120-minute chart shows a solid trend up since earnings March 28th. This
pre-revenue company beat earnings with less cash burn than expected. Another earnings
report is about a month aw
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.59 USD
−45.39 M USD
0.00 USD
46.35 M
About Zura Bio Limited
Sector
Industry
CEO
Robert Lisicki
Website
Headquarters
Henderson
Founded
2022
FIGI
BBG011FJXV49
Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.
ZURA - Upcoming Catalysts comingZura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and i
ZURA, time to SEED the UPSIDE after a $80M financing.ZURA is registering massive massive volume based on weekly data. Volume net buys have increase two-folds from its average numbers, from 2.3M average volume to 5.7M last trading day. A huge hint of things to come for this stock after a FWB:80M financing for its Phase 2 clinical trial for ZB-106 in
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of ZURA is 1.49 USD — it has increased by 8.76% in the past 24 hours. Watch Zura Bio Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Zura Bio Limited stocks are traded under the ticker ZURA.
ZURA stock has risen by 34.23% compared to the previous week, the month change is a 7.97% rise, over the last year Zura Bio Limited has showed a −57.18% decrease.
We've gathered analysts' opinions on Zura Bio Limited future price: according to them, ZURA price has a max estimate of 26.00 USD and a min estimate of 3.00 USD. Watch ZURA chart and read a more detailed Zura Bio Limited stock forecast: see what analysts think of Zura Bio Limited and suggest that you do with its stocks.
ZURA reached its all-time high on Mar 24, 2023 with the price of 37.55 USD, and its all-time low was 0.97 USD and was reached on Apr 4, 2025. View more price dynamics on ZURA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ZURA stock is 13.33% volatile and has beta coefficient of 2.14. Track Zura Bio Limited stock price on the chart and check out the list of the most volatile stocks — is Zura Bio Limited there?
Today Zura Bio Limited has the market capitalization of 93.67 M, it has decreased by −6.56% over the last week.
Yes, you can track Zura Bio Limited financials in yearly and quarterly reports right on TradingView.
Zura Bio Limited is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
ZURA earnings for the last quarter are −0.15 USD per share, whereas the estimation was −0.16 USD resulting in a 6.25% surprise. The estimated earnings for the next quarter are −0.16 USD per share. See more details about Zura Bio Limited earnings.
Zura Bio Limited revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ZURA net income for the last quarter is −9.05 M USD, while the quarter before that showed −22.94 M USD of net income which accounts for 60.56% change. Track more Zura Bio Limited financial stats to get the full picture.
No, ZURA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 23, 2025, the company has 30 employees. See our rating of the largest employees — is Zura Bio Limited on this list?
Like other stocks, ZURA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Zura Bio Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Zura Bio Limited technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Zura Bio Limited stock shows the sell signal. See more of Zura Bio Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.